Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.

Sadaf A, Hasan B, Das JK, Colan S, Alvi N.

Cochrane Database Syst Rev. 2018 Jul 12;7:CD011626. doi: 10.1002/14651858.CD011626.pub2. Review.

PMID:
29998494
2.
3.

Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.

Mathew RO, Schulman-Marcus J, Nichols EL, Newman JD, Bangalore S, Farkouh M, Sidhu MS.

Cardiovasc Drugs Ther. 2017 Dec;31(5-6):619-625. doi: 10.1007/s10557-017-6759-5. Review.

PMID:
29129003
4.

Chelation therapy in cardiovascular disease: an update.

Sultan S, Murarka S, Jahangir A, Mookadam F, Tajik AJ, Jahangir A.

Expert Rev Clin Pharmacol. 2017 Aug;10(8):843-854. doi: 10.1080/17512433.2017.1339601. Epub 2017 Jun 19. Review.

PMID:
28597699
5.

Deferiprone for the treatment of transfusional iron overload in thalassemia.

Belmont A, Kwiatkowski JL.

Expert Rev Hematol. 2017 Jun;10(6):493-503. doi: 10.1080/17474086.2017.1318052. Review.

PMID:
28448199
6.
7.

Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.

Aneni EC, Escolar E, Lamas GA.

Curr Atheroscler Rep. 2016 Dec;18(12):81. Review.

PMID:
27822681
8.

Gadolinium deposition in the brain: Lessons learned from other metals known to cross the blood-brain barrier.

Prybylski JP, Maxwell E, Coste Sanchez C, Jay M.

Magn Reson Imaging. 2016 Dec;34(10):1366-1372. doi: 10.1016/j.mri.2016.08.018. Epub 2016 Aug 28. Review.

PMID:
27580521
9.

Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.

Lamas GA, Navas-Acien A, Mark DB, Lee KL.

J Am Coll Cardiol. 2016 May 24;67(20):2411-2418. doi: 10.1016/j.jacc.2016.02.066. Review.

10.

Oxidative Stress and Cardiovascular Dysfunction Associated with Cadmium Exposure: Beneficial Effects of Curcumin and Tetrahydrocurcumin.

Kukongviriyapan U, Apaijit K, Kukongviriyapan V.

Tohoku J Exp Med. 2016 May;239(1):25-38. doi: 10.1620/tjem.239.25. Review.

11.

Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?

Lamas GA, Ergui I.

Expert Rev Cardiovasc Ther. 2016 Aug;14(8):927-38. doi: 10.1080/14779072.2016.1180977. Epub 2016 May 5. Review.

12.

Cardiac complications in thalassemia major.

Auger D, Pennell DJ.

Ann N Y Acad Sci. 2016 Mar;1368(1):56-64. doi: 10.1111/nyas.13026. Epub 2016 Mar 9. Review.

PMID:
26963698
13.

Chelation therapy in the treatment of cardiovascular diseases.

Ibad A, Khalid R, Thompson PD.

J Clin Lipidol. 2016 Jan-Feb;10(1):58-62. doi: 10.1016/j.jacl.2015.09.005. Epub 2015 Sep 25. Review.

PMID:
26892121
14.

Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.

Lamas GA, Issa OM.

Curr Cardiol Rep. 2016 Feb;18(2):20. doi: 10.1007/s11886-015-0690-9. Review.

PMID:
26797807
15.

Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.

Saliba AN, El Rassi F, Taher AT.

Expert Rev Hematol. 2016;9(2):151-68. doi: 10.1586/17474086.2016.1126176. Epub 2015 Dec 19. Review.

PMID:
26613264
16.

Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease.

Sheng R, Tang L, Jiang L, Hong L, Shi Y, Zhou N, Hu Y.

ACS Chem Neurosci. 2016 Jan 20;7(1):69-81. doi: 10.1021/acschemneuro.5b00224. Epub 2015 Oct 28. Review.

PMID:
26479744
17.

EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.

Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A.

Curr Cardiol Rep. 2015 Nov;17(11):96. doi: 10.1007/s11886-015-0656-y. Review.

PMID:
26364188
18.

Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium.

Brzóska MM, Borowska S, Tomczyk M.

Curr Drug Targets. 2016;17(12):1350-84. Review.

PMID:
25944010
19.

Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

Solenkova NV, Newman JD, Berger JS, Thurston G, Hochman JS, Lamas GA.

Am Heart J. 2014 Dec;168(6):812-22. doi: 10.1016/j.ahj.2014.07.007. Epub 2014 Jul 22. Review.

20.

Chelation therapy and cardiovascular disease: connecting scientific silos to benefit cardiac patients.

Peguero JG, Arenas I, Lamas GA.

Trends Cardiovasc Med. 2014 Aug;24(6):232-40. doi: 10.1016/j.tcm.2014.06.002. Epub 2014 Jun 12.

Supplemental Content

Loading ...
Support Center